A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions for use.

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Teal won FDA approval for a self-collection device after running a study at 16 sites in the U.S. Writing in the JAMA paper, ...

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed ...

“For too long, Johnson & Johnson has used tying arrangements and other tactics to interfere with fair competition from ...

Many companies forecast specific tariff charges. Then the White House and China agreed to a 90-day pause in their trade ...

The company will compete with a device Boston Scientific acquired for $850 million.

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

While venture funding is rising, federal policy upheaval may affect women’s health research more acutely than other fields, ...

Dave Rosa, Intuitive Surgical’s president, will take over as chief executive on July 1, as the surgical robot maker ...

Vicarious Surgical and SS Innovations marked progress toward bringing their robotic surgery systems to the U.S. market. The ...